2m 2m 2m 2m 2m 2m 2m
MOLECULAR SP ADS (MOLN)
NASDAQ
$3.88-$0.15 (-3.70%)
Price as of Jun 03, 2026 4:01 PM EDT- $157.5MMarket Cap
- 9.19%1-Year Change
- BiotechnologyIndustry
MOLECULAR SP ADS (MOLN)
$3.88-$0.15 (-3.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 5.0M -29.38% | 7.0M -96.29% | 189.6M +1,843.82% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 5.0M -29.38% | 7.0M -96.29% | 189.6M +1,843.82% | |
Sales and Marketing Expense | 15.2M -13.32% | 17.6M -9.19% | 19.4M -12.93% | 22.2M +27.41% | |
Research and Development Expense | -40.2M -17.30% | -48.6M -0.37% | -48.8M -3.87% | -50.7M -8.92% | |
Depreciation and Amortization Expense | 2.1M -9.50% | 2.4M -2.11% | 2.4M +1.34% | 2.4M -6.90% | |
Total Operating Expenses | 15.2M -13.32% | 17.6M -9.19% | 19.4M -12.93% | 22.2M +27.41% | |
Operating Profit | -58.1M -5.05% | -61.2M +0.18% | -61.1M -152.40% | 116.6M +283.88% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | 0 N/A | 0 -100.00% | 44,000 -89.62% | |
Income before Taxes | -61.7M +14.08% | -54.0M -12.81% | -62.0M -152.59% | 117.9M +284.77% | |
Income Taxes | 2,000 0.00% | 2,000 N/A | 0 N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -61.7M +14.08% | -54.0M -12.81% | -62.0M -152.59% | 117.9M +284.77% | |
Net Income from Continuing Operations Applicable to Common | -61.7M +14.08% | -54.0M -12.81% | -62.0M -152.59% | 117.9M +284.77% | |
Basic EPS and Net Income | -1.65 +3.77% | -1.59 -15.87% | -1.89 -152.07% | 3.63 +276.21% | |
Diluted EPS and Net Income | -1.65 +3.77% | -1.59 -15.87% | -1.89 -153.39% | 3.54 +271.84% | |
Basic Weighted Average Shares | 37.3M +9.52% | 34.0M +3.85% | 32.8M +0.93% | 32.5M +4.72% | |
Diluted Weighted Average Shares | 37.3M +9.52% | 34.0M +3.85% | 32.8M +0.93% | 32.5M +4.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 82.7M +29.40% | 63.9M -5.10% | 67.3M -23.47% | 87.9M +22.47% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 82.7M +29.40% | 63.9M -5.10% | 67.3M -23.47% | 87.9M +22.47% | |
Total Current Assets | 96.9M -37.21% | 154.3M -19.84% | 192.5M -24.45% | 254.8M +55.16% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 7.2M -11.18% | |
Total Long-Term Assets | 5.2M +23.17% | 4.2M -27.93% | 5.9M -21.49% | 7.5M -11.45% | |
Total Assets | 102.1M -35.59% | 158.5M -20.08% | 198.4M -24.37% | 262.3M +51.89% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.0M +2.24% | 10.8M -25.19% | 14.4M -16.43% | 17.3M -63.19% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.7M +75.99% | 6.1M -18.66% | 7.5M -23.72% | 9.8M -46.85% | |
Total Liabilities | 21.8M +28.90% | 16.9M -22.95% | 21.9M -19.08% | 27.1M -58.56% | |
Retained Earnings | -311.8M +26.58% | -246.3M +28.44% | -191.8M +50.07% | -127.8M -49.08% | |
Total Stockholders Equity | 80.3M -43.28% | 141.6M -19.72% | 176.4M -24.98% | 235.2M +119.19% | |
Total Shares Outstanding | 40.4M +0.03% | 40.4M +11.03% | 36.4M +0.86% | 36.0M +23.67% | |
Cash Flow | |||||
Cash from Operating Activities | -51.3M -13.49% | -59.2M +0.41% | -59.0M -149.77% | 118.6M +230.36% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 72.5M +79.20% | 40.5M -9.30% | 44.6M +144.14% | -101.1M +354.74% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.1M -107.96% | 14.4M +1,336.76% | -1.2M -25.67% | -1.6M -103.10% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -1,231.73% +41.86% | -868.26% -1,511.69% | 61.50% N/A | |
Return on Assets | -47.31% +56.20% | -30.29% +12.53% | -26.91% -149.66% | 54.19% N/A | |
Return on Equity | -55.55% +63.46% | -33.98% +12.83% | -30.12% -143.76% | 68.83% N/A | |
Revenue Growth | -100.00% +240.33% | -29.38% -69.48% | -96.29% -105.22% | 1,843.82% N/A | |
Current Ratio | 8.79 -38.59% | 14.31 +7.15% | 13.35 -9.60% | 14.77 N/A | |
Cash Ratio | 7.50 +26.56% | 5.92 +26.85% | 4.67 -8.42% | 5.10 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow